← All trials
NCT01887678
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 1, 2013
- Primary completion
- Jan 1, 2014
- Completion date
- Jan 1, 2014
- First posted
- —
- Last posted
- —
- Enrollment
- 287
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Biologische Heilmittel Heel GmbHLead sponsor
- Injury Care Medical CenterOverall official - principal investigator
- Provident Clinical ResearchOverall official - principal investigator
- Tucson Orthopaedic InstituteOverall official - principal investigator
- Hans Richard Barthel, M.D., Inc.Overall official - principal investigator
- Westlake Medical ResearchOverall official - principal investigator
- Riverside Clinical ResearchOverall official - principal investigator
- AppleMed Research, Inc.Overall official - principal investigator
- Sundance Clinical Research, LLCOverall official - principal investigator
- New Hope Clinical ResearchOverall official - principal investigator
- Manhattan Medical ResearchOverall official - principal investigator
- Clinical Inquest Center Ltd.Overall official - principal investigator
- Hillcrest Clinical ResearchOverall official - principal investigator
- Blair Orthopedic Associates, IncOverall official - principal investigator
- Clinical Research SolutionsOverall official - principal investigator
- Universal BioPharma Research Inc.Overall official - principal investigator
- PMG ResearchOverall official - principal investigator
- Sterling Research Group, LtdOverall official - principal investigator
- Research Across AmericaOverall official - principal investigator
- Radiant ResearchOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.